2018 Emerging Tumor Marker Diagnostic Testing Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing.  Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 

Contains 185 pages

Analysis of Cancer Diagnostic Technologies
And Strategic Profiles of Leading Suppliers

Current and Emerging Technologies
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others

Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
Artificial Intelligence
Flow Cytometry
Two Dimensional Gel Electrophoresis (2-DGE)
Biosensors
Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
Competitive Profiles
- Abbott
- AdnaGen
- Applied Gene Technologies
- Arca Biiopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus

- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila/Alere

South Africa Clinical Chemistry and Immunodiagnostic Markets 2018-2023: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities for Suppliers

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five

USD 3750 View Report

Nigeria Clinical Chemistry and Immunodiagnostic Markets 2018-2023: Volume and Sales Segment Forecasts for Routine and Special Chemistries, Endocrine Function, Immunoproteins, TDM, and Tumor Markers--Competitive Strategies, Opportunities for Suppliers

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five

USD 3750 View Report

Emerging Tumor Marker Testing Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies.

USD 3850 View Report

Emerging Tumor Marker Diagnostic Testing Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing.

USD 3850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available